Physician profile
Marta Lavery
NPI 1841642899
$3,611.68
in general payments reported to CMS, 2019-2025
14 companies · $20.78 in 2025
The $20.78 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $18.78 · 2021: $15.79 · 2022: $2,404 · 2023: $695 · 2024: $177 · 2025: $20.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Travel and Lodging: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.52 |
| Travel and Lodging | $137.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,542.20 | 2022-2023 | Da Vinci Sp |
| Medtronic, INC. | $361.69 | 2023-2025 | Interstim, Signia, Ligasure |
| Stryker Corporation | $145.62 | 2023 | Spy-Phi System |
| Axonics, INC. | $137.10 | 2023 | Axonics |
| Pfizer INC. | $113.68 | 2019 | |
| Exact Sciences Corporation | $111.11 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $40.54 | 2019 | |
| Alexion Pharmaceuticals, INC. | $35.32 | 2019-2020 | |
| Shire North American Group INC | $34.85 | 2019 | |
| Tela Bio, INC. | $32.10 | 2019 | |
| Heron Therapeutics, INC. | $15.79 | 2021 | |
| Boston Scientific Corporation | $15.49 | 2019 | |
| Braintree Laboratories, INC. | $14.03 | 2019 | |
| Tandem Diabetes Care, INC. | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Lavery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.